R. Douglas Shytle

7.8k total citations · 1 hit paper
68 papers, 5.9k citations indexed

About

R. Douglas Shytle is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, R. Douglas Shytle has authored 68 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 17 papers in Physiology and 15 papers in Cellular and Molecular Neuroscience. Recurrent topics in R. Douglas Shytle's work include Nicotinic Acetylcholine Receptors Study (19 papers), Obsessive-Compulsive Spectrum Disorders (12 papers) and Alzheimer's disease research and treatments (11 papers). R. Douglas Shytle is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (19 papers), Obsessive-Compulsive Spectrum Disorders (12 papers) and Alzheimer's disease research and treatments (11 papers). R. Douglas Shytle collaborates with scholars based in United States, Japan and China. R. Douglas Shytle's co-authors include Paul R. Sanberg, David V. Sheehan, Archie A. Silver, Kathy H. Sheehan, Berney J. Wilkinson, Yvonne Bannon, Saundra Stock, Jamison Rogers, Adam J. Smith and Jun Tan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, PLoS ONE and Biological Psychiatry.

In The Last Decade

R. Douglas Shytle

66 papers receiving 5.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reliability and Validity of the Mini International Neuropsychiatric Interview for Children and Adolescents (MINI-KID)

2010 1.2k citations David V. Sheehan, Kathy H. Sheehan et al. profile →

Peers

R. Douglas Shytle

PHYSI

CMN

PHARM

George S. Zubenko United States

Patricia A. Zunszain United Kingdom

Diane B. Miller United States

Young‐Chul Chung South Korea

Jean C. Shih United States

Hannu Alho Finland

Donald M. Kuhn United States

Ranji Cui China

Filippo Caraci Italy

Anat Biegon United States

George S. Zubenko United States

R. Douglas Shytle

1.7k ×0.9

1.6k ×1.5

PHYSI

1.2k ×1.2

669 ×0.7

CMN

928 ×1.0

PHARM

Citations per year, relative to R. Douglas Shytle R. Douglas Shytle (= 1×) peers George S. Zubenko

Countries citing papers authored by R. Douglas Shytle

Since Specialization

Citations

This map shows the geographic impact of R. Douglas Shytle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by R. Douglas Shytle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites R. Douglas Shytle more than expected).

Fields of papers citing papers by R. Douglas Shytle

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by R. Douglas Shytle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by R. Douglas Shytle. The network helps show where R. Douglas Shytle may publish in the future.

Co-authorship network of co-authors of R. Douglas Shytle

This figure shows the co-authorship network connecting the top 25 collaborators of R. Douglas Shytle. A scholar is included among the top collaborators of R. Douglas Shytle based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with R. Douglas Shytle. R. Douglas Shytle is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Sawmiller, Darrell, et al.. (2021). Propionate and Alzheimer’s Disease. Frontiers in Aging Neuroscience. 12. 580001–580001. 56 indexed citations

Ehrhart, Jared, Adam J. de Smith, Nicole Kuzmin‐Nichols, et al.. (2015). Humoral factors in ALS patients during disease progression. Journal of Neuroinflammation. 12(1). 127–127. 85 indexed citations

Bickford, Paula C., Yuji Kaneko, Bethany Grimmig, et al.. (2015). Nutraceutical intervention reverses the negative effects of blood from aged rats on stem cells. AGE. 37(5). 103–103. 13 indexed citations

Giunta, Brian, Jared Ehrhart, Demian Obregon, et al.. (2011). Antiretroviral medications disrupt microglial phagocytosis of β-amyloid and increase its production by neurons: Implications for HIV-associated neurocognitive disorders. Molecular Brain. 4(1). 23–23. 83 indexed citations

Giunta, Brian, et al.. (2010). Fish oil enhances anti-amyloidogenic properties of green tea EGCG in Tg2576 mice. Neuroscience Letters. 471(3). 134–138. 67 indexed citations

Bachstetter, Adam D., Jennifer N. Jernberg, Jennifer Vila, et al.. (2010). Spirulina Promotes Stem Cell Genesis and Protects against LPS Induced Declines in Neural Stem Cell Proliferation. PLoS ONE. 5(5). e10496–e10496. 54 indexed citations

Smith, Adam J., Brian Giunta, Paula C. Bickford, et al.. (2010). Nanolipidic particles improve the bioavailability and α-secretase inducing ability of epigallocatechin-3-gallate (EGCG) for the treatment of Alzheimer's disease. International Journal of Pharmaceutics. 389(1-2). 207–212. 202 indexed citations

Rezai‐Zadeh, Kavon, R. Douglas Shytle, Yun Bai, et al.. (2008). Flavonoid‐mediated presenilin‐1 phosphorylation reduces Alzheimer's disease β‐amyloid production. Journal of Cellular and Molecular Medicine. 13(3). 574–588. 123 indexed citations

Bickford, Paula C., Jun Tan, R. Douglas Shytle, et al.. (2006). Nutraceuticals Synergistically Promote Proliferation of Human Stem Cells. Stem Cells and Development. 15(1). 118–123. 66 indexed citations

10.

Ehrhart, Jared, Demian Obregon, Takashi Mori, et al.. (2005). Stimulation of cannabinoid receptor 2 (CB2) suppresses microglial activation. Journal of Neuroinflammation. 2(1). 29–29. 323 indexed citations

11.

Shytle, R. Douglas, Takashi Mori, Kirk Townsend, et al.. (2004). Cholinergic modulation of microglial activation by α7 nicotinic receptors. Journal of Neurochemistry. 89(2). 337–343. 461 indexed citations

12.

Shytle, R. Douglas, Archie A. Silver, Kathy H. Sheehan, David V. Sheehan, & Paul R. Sanberg. (2002). Neuronal nicotinic receptor inhibition for treating mood disorders preliminary controlled evidence with mecamylamine. Depression and Anxiety. 16(3). 89–92. 61 indexed citations

13.

Shytle, R. Douglas, Archie A. Silver, Ronald J. Lukas, et al.. (2002). Nicotinic acetylcholine receptors as targets for antidepressants. Molecular Psychiatry. 7(6). 525–535. 233 indexed citations

14.

Newman, Mary B., Ronald J. Lukas, Paul R. Sanberg, et al.. (2002). Nicotinic acetylcholine receptors on NT2 precursor cells and hNT (NT2-N) neurons. Developmental Brain Research. 139(1). 73–86. 11 indexed citations

15.

Newman, Mary B., Gary W. Arendash, R. Douglas Shytle, et al.. (2002). Nicotine's oxidative and antioxidant properties in CNS. Life Sciences. 71(24). 2807–2820. 81 indexed citations

16.

Newman, Mary B., S. J. Nazian, Paul R. Sanberg, David M. Diamond, & R. Douglas Shytle. (2001). Corticosterone-attenuating and anxiolytic properties of mecamylamine in the rat. Progress in Neuro-Psychopharmacology and Biological Psychiatry. 25(3). 609–620. 42 indexed citations

17.

Newman, Mary B., et al.. (2001). Nicotine induced seizures blocked by mecamylamine and its stereoisomers. Life Sciences. 69(22). 2583–2591. 21 indexed citations

18.

Silver, Archie A., R. Douglas Shytle, & Paul R. Sanberg. (2000). Mecamylamine in Tourette's Syndrome: A Two-Year Retrospective Case Study. Journal of Child and Adolescent Psychopharmacology. 10(2). 59–68. 44 indexed citations

19.

Newman, Mary B., R. Douglas Shytle, & Paul R. Sanberg. (1999). Locomotor behavioral effects of prenatal and postnatal nicotine exposure in rat offspring. Behavioural Pharmacology. 10(6). 699–706. 47 indexed citations

20.

Shytle, R. Douglas, Cesar V. Borlongan, & Paul R. Sanberg. (1995). Nicotine Blocks Kainic Acid-Induced Wet Dog Shakes in Rats. Neuropsychopharmacology. 13(3). 261–264. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact